Stay connected & subscribe to Rhenovia News Feed
Get English News Feed
May 2013 - Rhenovia Pharma opens now its 2nd Round of Financing to individuals, companies and investment organizations
Apr 2013 - Article in the economic newspaper La Tribune: 2nd Round of Fund Raising targetting 2.5 million euros to accelerate research on brain diseases of the nervous system
Feb 2013 - Press announcement: Rhenovia Pharma recognized as the world leader in biosimulation of the central nervous system
Nov 2012 - Press announcement: Rhenovia files two patent applications for RHEpatch™
Modeling & Simulation: CNS – Targeted Approach.
Model Behavior – Biosimulation offers a cost effective way of modeling complex data on rare and orphan diseases, offering hope for drug discovery and repositioning in the field.
Rhenovia Receives €2.5M to Further Develop Its Biosimulation Platform GEN News Highlights
Newsletter April 2008